关注
Andrew John Palmer
Andrew John Palmer
在 utas.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
The CORE Diabetes Model: projecting long-term clinical outcomes, costs and costeffectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and …
AJ Palmer, S Roze, WJ Valentine, ME Minshall, V Foos, FM Lurati, ...
Current medical research and opinion 20 (sup1), S5-S26, 2004
6172004
Projection of osteoporosis-related fractures and costs in China: 2010–2050
L Si, TM Winzenberg, Q Jiang, M Chen, AJ Palmer
Osteoporosis International 26, 1929-1937, 2015
4832015
Validation of the CORE Diabetes Model against epidemiological and clinical studies
AJ Palmera, S Rozea, WJ Valentinea, ME Minshallb, V Foosa, FM Luratia, ...
Current Medical Research and Opinion 20 (sup1), S27-S40, 2004
3542004
Unprecedented smoke‐related health burden associated with the 2019–20 bushfires in eastern Australia
N Borchers Arriagada, AJ Palmer, DMJS Bowman, GG Morgan, ...
Medical Journal of Australia 213 (6), 282-283, 2020
3002020
Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting
AJ Palmer, S Roze, WJ Valentine, P McEwan
Diabetes care 30 (6), 1638, 2007
291*2007
The relationship between return on investment and quality of study methodology in workplace health promotion programs
S Baxter, K Sanderson, AJ Venn, CL Blizzard, AJ Palmer
American Journal of Health Promotion 28 (6), 347-363, 2014
2282014
Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in …
AJ Palmer, S Roze, WJ Valentine, GA Spinas, JE Shaw, PZ Zimmet
Clinical therapeutics 26 (2), 304-321, 2004
1892004
Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study
P Gaede, WJ Valentine, AJ Palmer, DMD Tucker, M Lammert, HH Parving, ...
Diabetes care 31 (8), 1510-1515, 2008
1882008
Unprecedented health costs of smoke-related PM2.5 from the 2019–20 Australian megafires
FH Johnston, N Borchers-Arriagada, GG Morgan, B Jalaludin, AJ Palmer, ...
Nature Sustainability 4 (1), 42-47, 2021
1772021
A systematic review of cost-of-illness studies of multimorbidity
L Wang, L Si, F Cocker, AJ Palmer, K Sanderson
Applied health economics and health policy 16, 15-29, 2018
1662018
Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain
JA Ray, WJ Valentine, K Secnik, AK Oglesby, A Cordony, A Gordois, ...
Current medical research and opinion 21 (10), 1617-1629, 2005
1642005
Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial
D Morton, M Seymour, L Magill, K Handley, J Glasbey, B Glimelius, ...
Journal of clinical oncology 41 (8), 1541-1552, 2023
1542023
Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study
MS Cooper, AJ Palmer, MJ Seibel
Osteoporosis international 23, 97-107, 2012
1432012
Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised …
AJ Palmer, K Koppenhagen, B Kirchhof, U Weber, R Bergemann
Pathophysiology of Haemostasis and Thrombosis 27 (2), 75-84, 1997
1361997
Recent trends in life expectancy for people with type 1 diabetes in Sweden
D Petrie, TWC Lung, A Rawshani, AJ Palmer, AM Svensson, B Eliasson, ...
Diabetologia 59, 1167-1176, 2016
1312016
Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK
S Roze, WJ Valentine, KE Zakrzewska, AJ Palmer
Diabetic Medicine 22 (9), 1239-1245, 2005
1292005
Association between fire smoke fine particulate matter and asthma-related outcomes: Systematic review and meta-analysis
NB Arriagada, JA Horsley, AJ Palmer, GG Morgan, R Tham, FH Johnston
Environmental research 179, 108777, 2019
1272019
The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective
AJ Palmer, C Weiss, PP Sendi, K Neeser, A Brandt, G Singh, H Wenzel, ...
Diabetologia 43, 13-26, 2000
1212000
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and …
AJ Palmer, L Annemans, S Roze, M Lamotte, P Lapuerta, R Chen, ...
Diabetes Care 27 (8), 1897-1903, 2004
1162004
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA
AJ Palmer, WJ Valentine, R Chen, N Mehin, S Gabriel, B Bregman, ...
Nephrology Dialysis Transplantation 23 (4), 1216-1223, 2008
1132008
系统目前无法执行此操作,请稍后再试。
文章 1–20